Rituximab, a non-TNF DMARD, is also used in RA to suppress CD20+ B cells and decrease the immune response; similarly, abatacept works to inhibit T cell activation and decrease the immune response [70]. This evidence concerns the gene TNF and rheumatoid arthritis.